DOI: https://doi.org/10.22141/2224-0721.3.59.2014.76598

Glycemic Memory as a Pathogenic Basis for Modern Antidiabetic Therapy Algorithm Forming

V.V. Poltorak, N.S. Krasova, M.Yu. Gorshunskaya

Abstract


Prevention/delay of the development of vascular complications remains one of major challenges in treatment of diabetes mellitus. Epidemiological studies have shown lack of efficacy of stable glycemic control in patients with long-existing diabetes. This phenomenon, confirmed in animal models and analyzed at the molecular genetic level, is called metabolic/glycemic memory and associated with epigenetic modifications of gene expression. On the other hand, it has been proven that early intensive intervention in type 1 and 2 diabetes mellitus reduces the risk of micro- and macrovascular complications development and progression, forming the basis for long-term favorable effects that persist beyond normoglycemia. The foregoing justifies change of therapeutic approach in diabetes mellitus since the moment of establishing diagnosis for the early and maximum safely achievement of blood glucose and glycosylated hemoglobin levels close to normal ones.


Keywords


glycemic memory; epigenetics; diabetes mellitus; vascular complications

References


Diabetes mellitus, fasting glucose, and risk of cause-specific death / S.R. Seshasai, S. Kaptoge, A. Thompson [et al.]; The Emerging Risk Factors Collaboration // N. Engl. J. Med. — 2011. — Vol. 364. — P. 829-841.

Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitus / D.M. Nathan, J. Lachin, P. Cleary [et al.]; Diabetes Control and Complications Trial; Epidemiology of Diabetes Interventions and Complications Research Group // N. Engl. J. Med. — 2003. — Vol. 348. — P. 2294-2303.

Diabetes control and complications trial/epidemiology of diabetes interventions and complications research group. Prolonged effect of intensive therapy on the risk of retinopathy complications in patients with type 1 diabetes mellitus. Ten years after the diabetes control and complications trial [Text] // Arch. Ophtalmol. — 2008. — Vol. 126. — P. 1707-1715.

Vibration perception threshold as a measure of distal symmetrical peripheral neuropathy in type 1 diabetes: results from the DCCT/EDIC study [Text] / C.L. Martin, B.H. Waberski, R. Pop-Busui [et al.] // Diabetes Care. — 2010. — Vol. 33. — P. 2635-2641.

Association between cardiovascular autonomic neuropathy and left ventricular dysfunction in the diabetes control and complications trial/epidemiology of diabetes interventions and complications (DCCT/EDIC) study [Text] / R. Pop-Busui, P.A. Clearly, B.H. Braffett [et al.] // J. Am. Coll. Cardiol. — 2013. — Vol. 61. — P. 447-454.

Intensive diabetes therapy and glomerular filtration rate in type 1 diabetes [Text] / I.H. De Boer, W. Sun, P.A. Clear [et al.] // N. Engl. J. Med. — 2011. — Vol. 365. — P. 2366-2376.

UKPDS Group. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study // BMJ. — 2000. — Vol. 321. — P. 405-412.

10-year follow-up of intensive glucose control in type 2 diabetes / R.R. Holman, S.K. Paul, M.A. Bethel [et al.] // N. Engl. J. Med. — 2008. — Vol. 359. — P. 1577-1589.

The ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with Type 2 Diabetes // N. Engl. J. Med. — 2008. — Vol. 358. — P. 2560-2572.

Intensive blood glucose control and complications in American veterans with type 2 diabetes [Text] / W. Duckworth, C. Abraria, T. Moritz [et al.] // N. Engl. J. Med. — 2009. — Vol. 360. — P. 129-139.

Effects of intensive glucose lowering in type 2 diabetes [Text] / H.C. Gerstein, M.E. Miller, R.P. Byington [et al.] // N. Engl. J. Med. — 2008. — Vol. 358. — P. 2545-2559.

Engerman R.L. Progression of incipient diabetic retinopathy during good glycemic control / R.L. Engerman, T.S. Kern // Diabetes. — 1987. — Vol. 36. — P. 808-812.

Kowluru R.A. Effect of re-institution of good glycemic control on retinal oxidative stress and nitrative stress in diabetic rats // Diabetes. — 2003. — Vol. 52. — P. 818-823.

Kowluru R.A. Reversal of hyperglycemia and diabetic nephropathy: effect of reinstitution of good metabolic control on oxidative stress in the kidney of diabetic rats / R.A. Kowluru, S.N. Abbas, S. Odenbach // J. Diabetes Complicat. — 2004. — Vol. 18. — P. 282-288.

Hyperglycemia induces a dynamic cooperativity of histone methylase and demethylase enzymes associated with gene-activating epigenetic marks that coexist on the lysine tail / D. Brasacchio, J. Okabe, M.E. Cooper, A. El-Osta // Diabetes. — 2009. — Vol. 58. — P. 1229-1236.

Overexpression of fibronectin induced by diabetes or high glucose: phenomenon with a memory / S. Roy, R. Sala, E. Cagliero, M. Lorenzi // Proc. Natl. Acad. Sci. USA. — 1990. — Vol. 87. — P. 404-408.

Holliday R. Epigenetics. A historical overview [Text] // Epigenetics. — 2006. — Vol. 1, № 2. — Р. 76-80.

MicroRNA-29b induces global DNA hypomethylation and tumor suppressоr gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1 [Text] / R. Garzon, S. Liu, M. Fabbri [et al.] // Blood. — 2009. — Vol. 113. — P. 6411-6418.

Reik W. Stability and flexibility of epigenetic gene regulation in mammalian development [Text] // Nature. — 2007. — Vol. 447. — P. 425-432.

Epigenetic differences arise during the lifetime of monozygotic twins [Text] / M.F. Fraga, E. Ballestar, M.F. Paz [et al.] // PNAS. — 2005. — Vol. 102. — P. 10604-10609. doi: 10.1073/pnas.0500398102.

Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia [Text] / A. El-Osta, D. Brasacchio, D. Yao [et al.] // J. Exp. Med. — 2008. — Vol. 205. — P. 2409-2417.

Brownlee M. The pathobiology of diabetes complications: a unifying mechanism [Text] // Diabetes. — 2005. — Vol. 54. — P. 1615-1625.

Stitt A.W. The role of advanced glycation in the pathogenesis of diabetic retinopathy [Text] // Exp. Mol. Pathol. — 2003. — Vol. 1. — P. 95-108.

Siebel A.L. Glycemic memory associated epigenetic changes [Text] / A.L. Siebel, A.Z. Fernandez, A. El-Osta // Biochem. Pharmacol. — 2010. — Vol. 80. — P. 1853-1859.

Cooper M. Epigenetics: mechanisms and implications for diabetic complications [Text] / M. Cooper, A. El-Osta // Circ. Res. — 2010. — Vol. 107. — P. 1407-1413.

SIRT1, p66(Shc), and Set7/9 in vascular hyperglycemic memory: bringing all the strands together [Text] / F. Paneni, M. Volpe, T.F. Luscher, F. Cosentino // Diabetes. — 2013. — Vol. 62. — P. 1800-1807. doi: 10.2337/db12-1648.

Brownlee M. Biochemistry and molecular cell biology of diabetic complications [Text] // Nature. — 2001. — Vol. 414. — P. 813-820.

El Osta A. Glycemic memory [Text] // Curr. Opin. Lipidol. — 2012. — Vol. 23. — P. 24-29. doi: 10.1097/MOL.0b013e32834f319d

Reactive oxygen species mediate a cellular «memory» of high glucose stress signaling [Text] / M.A. Ihnat, J.E. Thorpe, C.D. Camat [et al.] // Diabetologia. — 2007. — Vol. 50. — P. 1523-1531.

DeFronzo R.A. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus [Text] // Diabetes. — 2009. — Vol. 58. — P. 773-795.

Bernstein B.E. The mammalian epigenome [Text] / B.E. Berstein, A. Meissner, E.S. Lander // Cell. — 2007. — Vol. 128. — P. 669-681.

De Nigris F. New insights in the transcriptional activity and coregulator molecules in the arterial wall [Text] / F. de Nigris, L.O. Lerman, C. Napoli // Int. J. Cardiol. — 2002. — Vol. 86. — P. 153-168.

Plutzki J. The PPAR-RXR transcriptional complex in the vasculature: energy in the balance [Text] // Circ. Res. — 2011. — Vol. 108. — P. 1002-1016. doi: 10.1161/CIRCRESAHA.110.226860.

Role of peroxisome proliferation-activated receptor-γ in atherosclerosis: an update [Text] / N. Wang, R. Yin, Y. Liu [et al.] // Circ. J. — 2011. — Vol. 75. — P. 528-535. doi: 10.1253/circj.CJ-11-0060.

Lund G. Atherosclerosis: An epigenetic balancing act that goes wrong [Text] / G. Lund, S. Zaina // Curr. Atheroscler. Rep. — 2011. — Vol. 13. — P. 208-214. doi: 10.1007/s11883-011-0174-3.

De Santa Olalla L.M. N-3 fatty acids in glucose metabolism and insulin sensitivity [Text] / L.M. de Santa Olalla, F.J.S. Muniz, M.P. Vaquero // Nutr. Hosp. — 2009. — Vol. 24. — P. 113-127.

NF-kappaB regulation: the nuclear response [Text] / A.K. Mankan, M.W. Lawless, S.G. Gray [et al.] // J. Cell. Mol. Med. — 2009. — Vol. 13. — P. 631-643. doi: 10.1111/j.1582-4934.2009.00632.x.

Multifactorial intervention and cardiovascular diseases in patients with type 2 diabetes [Text] / P. Gaede, P. Vedel, N. Larsen [et al.] // N. Engl. J. Med. — 2003. — Vol. 348. — P. 383-393. doi: 10.1056/NEJMoa021778.

Effect of a multifactorial intervention oh mortality in type 2 diabetes [Text] / P. Gaede, H. Lund-Andersen, H.H. Parving [et al.] // N. Engl. J. Med. — 2008. — Vol. 358. — P. 580-591. doi: 10.1056/NEJMoa0706245.

Effect of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with type 2 diabetes detected by screening (ADDITION Europe): a cluster-randomized trial [Text] / S.J. Griffin, K. Borch-Johnsen, M.J. Davies [et al.] // Lancet. — 2011. — Vol. 378. — P. 156-167. doi: 10.1016/S0140-6736(11)60698-3.

Primary prevention of macroangiopathy in patients with short-duration type 2 diabetes by intensified multyfactorial intervention: seven-year follow-up of diabetes complications in Chinese [Text] / Y. Yang, I.J. Yao, L.J. Du [et al.] // Diabetes Care. — 2012. doi: 10.2337/dc12-0227.

Basal insulin and cardiovascular and other outcomes in dysglycemia [Text] / H.C. Gerstein, J. Bosch, G.R. Dagenais [et al.] // N. Engl. J. Med. — 2012. — Vol. 367. — P. 319-328. doi: 10.1056/NEJMoa1203858.

The ORIGINALE Study. http://origintrial.org/Assets/PDF/ORIGINALE%20Protocol.pdf

Summary of revisions to the 2014 clinical practice recommendations [Text] / American Diabetes Association // Diabetes Care. — 2014. — Vol. 37, Suppl. 1. — P. S4-S80. doi: 10.2337/dc14-S004.

Circulating concentrations of insulin markers and coronary heart disease: a quantitative review of 19 Western prospective studies [Text] / N. Sarwar, N. Sattar, V. Gudnason, J. Danesh // Eur. Heart J. — 2007. — Vol. 28. — P. 2491-2497. doi: 10.1093/eurheartj/ehm115.

Jandeleit-Dahm K.A. Insulin and cardiovascular disease: biomarker or association? [Text] / K.A. Jandeleit-Dahm, S.P. Gray // Diabetologia. — 2012. — Vol. 55. — P. 3145-3151. doi: 10.1007/s00125-012-2729-4.

Management of hyperglycemia in type 2 diabetes: a patient-centered approach. Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) [Text] / S.E. Inzucchi, R.M. Bergenstal, J.B. Buse [et al.] // Diabetes Care. — 2012. — Vol. 35. — P. 1-16. doi: 10.2337/dc12-0413.






Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

 

© "Publishing House "Zaslavsky", 1997-2019

 

   Seo анализ сайта